151 related articles for article (PubMed ID: 19951107)
1. Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.
van Thiel PP; Leenstra T; Kager PA; de Vries HJ; van Vugt M; van der Meide WF; Bart A; Zeegelaar JE; van der Sluis A; Schallig HD; van Gool T; Faber WR; de Vries PJ
Clin Infect Dis; 2010 Jan; 50(1):80-3. PubMed ID: 19951107
[TBL] [Abstract][Full Text] [Related]
2. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.
Soto J; Toledo J; Gutierrez P; Nicholls RS; Padilla J; Engel J; Fischer C; Voss A; Berman J
Clin Infect Dis; 2001 Oct; 33(7):E57-61. PubMed ID: 11528586
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.
van Thiel PP; Leenstra T; de Vries HJ; van der Sluis A; van Gool T; Krull AC; van Vugt M; de Vries PJ; Zeegelaar JE; Bart A; van der Meide WF; Schallig HD; Faber WR; Kager PA
Am J Trop Med Hyg; 2010 Dec; 83(6):1295-300. PubMed ID: 21118937
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine for new world cutaneous leishmaniasis.
Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
[TBL] [Abstract][Full Text] [Related]
6. Treatment of New World cutaneous leishmaniasis with miltefosine.
Soto J; Berman J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S34-40. PubMed ID: 16930649
[TBL] [Abstract][Full Text] [Related]
7. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
[TBL] [Abstract][Full Text] [Related]
8. First case of typical Old World cutaneous leishmaniasis treated with miltefosine.
Stojkovic M; Junghanss T; Krause E; Davidson RN
Int J Dermatol; 2007 Apr; 46(4):385-7. PubMed ID: 17442078
[TBL] [Abstract][Full Text] [Related]
9. [Miltefosine: a new remedy for leishmaniasis].
Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
[TBL] [Abstract][Full Text] [Related]
10. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
[TBL] [Abstract][Full Text] [Related]
11. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
[TBL] [Abstract][Full Text] [Related]
12. Two cases of cutaneous leishmaniasis in Dutch military personnel treated with oral miltefosine.
van der Snoek EM; Couwenberg SM; Stijnis C; Kortbeek LM; Schadd EM
J R Army Med Corps; 2017 Feb; 163(1):68-70. PubMed ID: 26661280
[TBL] [Abstract][Full Text] [Related]
13. Miltefosine in cutaneous leishmaniasis.
Rahman SB; ul Bari A; Mumtaz N
J Coll Physicians Surg Pak; 2007 Mar; 17(3):132-5. PubMed ID: 17374296
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a married couple for American leishmaniasis with miltefosine.
Wöhrl S; Schnedl J; Auer H; Walochnik J; Stingl G; Geusau A
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):258-9. PubMed ID: 18211436
[No Abstract] [Full Text] [Related]
15. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.
Dorlo TP; van Thiel PP; Huitema AD; Keizer RJ; de Vries HJ; Beijnen JH; de Vries PJ
Antimicrob Agents Chemother; 2008 Aug; 52(8):2855-60. PubMed ID: 18519729
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous leishmaniasis with lymphadenopathy due to Leishmania donovani.
Faber WR; Wonders J; Jensema AJ; Chocholova E; Kager PA
Clin Exp Dermatol; 2009 Jul; 34(5):e196-8. PubMed ID: 19077092
[TBL] [Abstract][Full Text] [Related]
18. Case Reports: Late Emergence of Cutaneous Leishmaniasis in an Immunocompromised Patient in a Non-Endemic Setting.
New D; Rogers BA
Am J Trop Med Hyg; 2019 Jan; 100(1):115-116. PubMed ID: 30520412
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA.
de Vries PJ; van der Meide WF; Godfried MH; Schallig HD; Dinant HJ; Faber WR
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1183-6. PubMed ID: 16678871
[TBL] [Abstract][Full Text] [Related]
20. Treatment of leishmaniasis with miltefosine: 2008 status.
Berman JJ
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
